Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: J Surg Oncol. 2018 Aug 16;118(3):455–462. doi: 10.1002/jso.25183

Table 3.

Postoperative Complications for Patients with Adenocarcinoma of the Pancreas after Pancreaticoduodenectomy within 30-days of the procedure

Neoadjuvant Therapy Initial Surgery p-value
N= 926 N= 2,822
Postoperative death, n (%) 16 (1.7%) 56 (2.0%) 0.622
Overall complication, n (%) 517 (55.8%) 1,554 (55.1%) 0.685
30-day Readmission, n (%) 154 (16.6%) 424 (15.0%) 0.24
Superficial SSI, n (%) 89 (9.6%) 253 (9.0%) 0.554
Deep incisional SSI, n (%) 20 (2.2%) 59 (2.1%) 0.899
Organ space SSI, n (%) 76 (8.2%) 321 (11.4%) 0.007
UTI, n (%) 40 (4.3%) 92 (3.3%) 0.129
Pneumonia, n (%) 21 (2.3%) 108 (3.8%) 0.024
Pulmonary embolism, n (%) 6 (0.7%) 35 (1.2%) 0.133
DVT, n (%) 27 (2.9%) 79 (2.8%) 0.853
Sepsis, n (%) 74 (8.0%) 232 (8.2%) 0.825
Septic Shock, n (%) 26 (2.8%) 84 (3.0%) 0.792
Acute renal insufficiency, n (%) 2 (0.2%) 19 (0.7%) 0.106
Acute renal failure, n (%) 5 (0.5%) 26 (0.9%) 0.266
Stroke, n (%) 1 (0.1%) 9 (0.3%) 0.28
Myocardial infarction, n (%) 6 (0.7%) 27 (1.0%) 0.383
Cardiac Arrest, n (%) 8 (0.9%) 35 (1.2%) 0.351
Wound dehiscence, n (%) 9 (1.0%) 34 (1.2%) 0.564
Reoperation, n (%) 49 (5.3%) 157 (5.5%) 0.784
Pancreatic fistula, n (%) 85 (9.2%) 414 (14.8%) <0.001
Grade A (ISGPF) 55 (6.0%) 278 (10.0%) < 0.001
Grade B (ISGPF) 28 (3.0%) 104 (3.7%) 0.331
Grade C (ISGPF) 2 (0.2%) 32 (1.2%) 0.01
Delayed gastric emptying, n (%) 125 (13.8%) 481 (17.6%) 0.008
Percutaneous drainage, n (%) 91 (10.0%) 297 (10.8%) 0.473
Perioperative transfusion, n (%) 255 (27.5%) 596 (21.1%) <0.001
Clavien-Dino Complication, n (%)
Grade 1 2 (0.2%) 19 (0.7%) 0.106
Grade 2 430 (46.4%) 1,247 (44.2%) 0.233
Grade 3 117 (12.6%) 419 (14.9%) 0.095
Grade 4 54 (5.8%) 192 (6.8%) 0.3
Grade 5 (death) 16 (1.7%) 56 (2.0%) 0.622
Complication, n (%)
Minor (Clavien-Dino 1–2) 426 (46%) 1,232 (43.7%) 0.212
Severe (Clavien-Dino 3–5) 155 (16.7%) 516 (18.3%) 0.287

SSI surgical site infection; UTI urinary tract infection; DVT deep venous thrombus; ISGPF International Study Group for Pancreatic Fistula